Price
$11.75
Decreased by -2.00%
Dollar Volume
1.15 M
ADR%
6.6
Earnings Report Date (estimate)
Mar 13, 23 (-0.43)
Market Cap.
445.98 M
Shares Float
12.71 M
Shares Outstanding
37.96 M
Beta
0.00
Price / Earnings
-8.17
BPR
170.43
20D Range
9.61 12.85
50D Range
8.50 13.54
200D Range
8.02 16.57
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 7, 22 -0.47
Decreased by -51.61%
-0.44
Decreased by -6.82%
Aug 8, 22 -0.47
Decreased by -135.00%
-0.37
Decreased by -27.03%
May 5, 22 -0.44
Increased by +87.57%
-0.39
Decreased by -12.82%
Mar 14, 22 -0.47 -0.31
Decreased by -51.61%
Nov 8, 21 -0.31 -0.26
Decreased by -19.23%
Aug 10, 21 -0.20 -0.23
Increased by +13.04%
May 18, 21 -3.54 -0.17
Decreased by -1.98 K%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 18.85 M
Increased by +39.89%
-17.87 M
Decreased by -53.84%
Decreased by -94.80%
Decreased by -9.97%
Jun 30, 22 17.89 M
Increased by +36.90%
-17.50 M
Decreased by -214.49%
Decreased by -97.77%
Decreased by -129.72%
Mar 31, 22 16.89 M
Increased by +38.34%
-16.40 M
Decreased by -102.91%
Decreased by -97.07%
Decreased by -46.67%
Dec 31, 21 -10.39 M
Decreased by -180.48%
-17.67 M
Decreased by -210.38%
Increased by +170.11%
Increased by +485.64%
Sep 30, 21 13.48 M
Increased by +35.38%
-11.62 M
Decreased by -171.17%
Decreased by -86.21%
Decreased by -100.30%
Jun 30, 21 13.07 M
Increased by +52.70%
-5.56 M
Decreased by -21.33%
Decreased by -42.56%
Increased by +20.54%
Mar 31, 21 12.21 M
Increased by +10.81%
-8.08 M
Decreased by -277.13%
Decreased by -66.18%
Decreased by -240.35%
Dec 31, 20 12.91 M - -5.69 M -
Decreased by -44.11%
-
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.